Published: August 07, 2009
Biomet Announces Leadership Transition at Dental Subsidiary, Biomet 3i
WARSAW, Ind. - (BUSINESS WIRE) - Biomet, Inc. announced today that Steve Schiess, President of Biomet 3i,
has informed Biomet management of his decision to retire from Biomet 3i,
a leading manufacturer of dental reconstructive implants and related
products.
"We thank Steve for his 11 years of leadership at Biomet 3i," said Jeff
Binder, Biomet President and CEO. "He has made many contributions along
the way and will be missed. We wish him the very best in his future
endeavors."
Biomet has appointed Maggie Anderson to the position of President,
Biomet 3i, effective immediately.
Ms. Anderson most recently served as a member of the TPG Capital
management team, working closely with Biomet and Biomet 3i management
over the last 18 months on strategic planning, innovation, and
operations. Prior to that, she worked with Fenwal, a transfusion
therapies business, to improve performance.
Prior to joining TPG, Ms. Anderson was a Director at AlixPartners, where
she led the transformation efforts of New World Pasta and dj Orthopedics
(now DJO Inc.). She also spent 10 years with General Motors in diverse
roles of increasing responsibility, including advanced manufacturing
engineering, new program development, quality, operations, production
control and logistics. She holds a BS from General Motors Engineering
and Management Institute and an MBA from Wright State University.
"We are very pleased to have Maggie join the Biomet team," said Mr.
Binder. "She has excellent strategic and operational skills and is
passionate about our business and the future of Biomet 3i."
About Biomet
Biomet, Inc. and its subsidiaries design, manufacture and market
products used primarily by musculoskeletal medical specialists in both
surgical and non-surgical therapy. Biomet's product portfolio
encompasses reconstructive products, including orthopedic joint
replacement devices, bone cements and accessories, autologous therapies
and dental reconstructive implants; fixation products, including
electrical bone growth stimulators, internal and external orthopedic
fixation devices, craniomaxillofacial implants and bone substitute
materials; spinal products, including spinal stimulation devices, spinal
hardware and orthobiologics; and other products, such as arthroscopy
products and softgoods and bracing products. Headquartered in Warsaw,
Indiana, Biomet and its subsidiaries currently distribute products in
approximately 90 countries.
Biomet, Inc.
Bill Kolter, 574-372-1535
Corporate Vice
President, Public Affairs
or
Barbara Goslee, 574-372-1514
Director,
Corporate Communications
Copyright © 2010, Business Wire, Inc., All rights reserved.
Copyright © 2010, NewsBlaze,
Daily News
Tags: Business wire, Healthcare, ohio, Health